Ms. Anam Khan | Pharmaceutics | Best Researcher Award
Marburg University | Germany
Dr. Anam Sajjad Khan is an enthusiastic Ph.D. researcher at the Philipps University of Marburg, Germany, specializing in nanocarriers for oral and dermal drug delivery. Her research expertise encompasses physicochemical characterization, formulation optimization, and ex-vivo study models for enhancing drug bioavailability and therapeutic performance. With a strong academic foundation, she holds a Master of Philosophy in Pharmaceutics and a Doctor of Pharmacy degree from Quaid-i-Azam University, Islamabad, where she developed a keen interest in nanomedicine and cosmetology. Her doctoral work is focused on developing innovative nanocarrier systems for targeted and controlled drug delivery applications. Dr. Khan has contributed to the scientific community through one published document. Alongside her academic pursuits, she has gained professional experience as a Drug Inspector with the Provincial Health Department of Khyber Pakhtunkhwa, ensuring regulatory compliance within the pharmaceutical sector, and as a Lecturer at Abasyn University Islamabad, where she taught core pharmaceutical subjects and participated in academic committees. Her dedication to research and education has been recognized through multiple awards and honors, including a prestigious DAAD research grant for doctoral studies in Germany and first position in a poster presentation at an international conference. Multilingual in English, German, Urdu, and Pashto, Dr. Khan continues to advance her research in nanotechnology-based drug delivery systems, contributing to the evolving landscape of pharmaceutical sciences and nanomedicine.
Profile: Scopus
Featured Publications
Roscettia, L., Keck, C. M., Chaiprateep, E., Sehra, T., Alkhaldi, M., Khan, A. S., Sengupta, S., Busch, L., Kleuser, B., Meinke, M. C., & Klein, A. L. (2025). Enhanced follicular penetration of antiseptics using nanocrystals – investigated via novel hair follicle content removal method. International Journal of Pharmaceutics, 685, Article 122435